The current and future role of sequence-based analysis in prostate cancer treatment

Personalized Medicine
Won Kim, Phillip G Febbo

Abstract

Prostate cancer is the most commonly diagnosed, nondermatologic malignancy in US men. Localized disease can be managed through active surveillance or curative, locally directed therapies, but 30% of men treated with surgery or radiation will need additional (often systemic) treatment for relapsed disease. While spectacular advances in medical treatment of advanced prostate cancer have improved the quality and duration of patients' lives, metastatic prostate cancer remains an incurable, lethal disease that requires additional therapies and better treatment strategies. The advent of ultra-high-throughput sequencing technology provides an opportunity to comprehensively assess the constellation of genetic and molecular events underlying each patient's tumor, and promises to enhance our ability to deliver specifically tailored personalized treatment to men with prostate cancer. The known biological and clinical heterogeneity of prostate cancer presents both opportunities and challenges to the application and utilization of sequence-based analysis to guide prostate cancer treatment.

References

Aug 1, 1987·Endocrine Reviews·G R CunhaY Sugimura
Oct 20, 1993·Journal of the National Cancer Institute·N M NavoneC J Conti
Nov 22, 1994·Proceedings of the National Academy of Sciences of the United States of America·W H LeeW G Nelson
Apr 24, 1999·Genes & Development·R Bhatia-GaurM M Shen
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Jan 2, 2004·Nature Medicine·Charlie D ChenCharles L Sawyers
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe GiacconeDavid H Johnson
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstDavid H Johnson
Mar 18, 2004·Cancer Research·Srinivasan YegnasubramanianWilliam G Nelson
May 28, 2004·The New England Journal of Medicine·Ian M ThompsonCharles A Coltman
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tsutomu NishiyamaKota Takahashi
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Oct 29, 2005·Science·Scott A TomlinsArul M Chinnaiyan
Apr 6, 2006·Cancer Research·Scott A TomlinsArul M Chinnaiyan
Oct 13, 2006·Neoplasia : an International Journal for Oncology Research·Nuno CerveiraManuel R Teixeira
Oct 25, 2006·Neoplasia : an International Journal for Oncology Research·Bharathi LaxmanArul M Chinnaiyan
Feb 22, 2007·Current Molecular Medicine·David A HanauerArul M Chinnaiyan
Mar 6, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Rohit MehraRajal B Shah
Sep 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daphne HesselsJack A Schalken
Feb 20, 2008·Neoplasia : an International Journal for Oncology Research·Scott A TomlinsArul M Chinnaiyan
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Juan-Miguel MosqueraMark A Rubin
Jun 10, 2008·Cancer Cell·Scott A TomlinsArul M Chinnaiyan
Mar 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Prateek MendirattaPhillip G Febbo
Apr 28, 2009·Nature Genetics·Jennifer C KingCharles L Sawyers
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lorenzo RichiardiFranco Merletti
Jul 14, 2009·Proceedings of the National Academy of Sciences of the United States of America·Yang ZongOwen N Witte
Oct 1, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fiona M PlattMargaret A Knowles
Nov 26, 2009·Science·Ram-Shankar ManiArul M Chinnaiyan
Dec 18, 2009·Nature·Erin D PleasanceMichael R Stratton
May 27, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew J ArmstrongMichael A Carducci
Jun 8, 2010·Nature Medicine·Nallasivam PalanisamyArul M Chinnaiyan
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Jun 29, 2010·Cancer Cell·Barry S TaylorWilliam L Gerald

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
PCR
RNA-seq

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.